Nadir görülen bir restriktif kardiyomiyopati olgusu: Hidradenitis suppurativa
Öz
Anahtar Kelimeler
Kaynakça
- 1. Girouard, SD, Falk RH, Rennke, HG, Merola JF. Hidradenitis suppurativa resulting in systemic amyloid A amyloidosis: A case report and review of the literature. Dermatology Online Journal 2012; 18: 2
- 2.Ilgen U, Çelebi ZK., Kuzu I, Kutlay S, Nergizoglu G, Ates K. Renal amyloidosis secondary to hidradenitis suppurativa. Clinical Kidney Journal 2013; 6: 667–8.
- 3.Montes-Romero JA, Callejas-Rubio JL, Sanchez-Cano D, Gonzalez-Martínez FJ, Navas-Parejo A, Ortego-Centeno N. Amyloidosis secondary to hidradenitis suppurativa. Exceptional response to infliximab. European Journal of Internal Medicine 2018; 19: 32–3.
- 4.Fernandez-Nebro A, Alejandro O, Castro MC et al. Long-term TNFalfa blockade in patients with amyloid A amyloidosis complicating rheumatic diseases. The American Journal of Medicine 2010; 123: 454–61.
- 5. Pinney JH, Smith CJ, Taube JB et al. Systemic amyloidosis in England: an epidemiological study. Br J Haematol 2013; 161: 525-32.
- 6. Schandorff KD, Miller IM, Krustrup D, Jemec GB, Marckmann P. Renal amyloid A amyloidosis as a complication of hidradenitis suppurativa. Clinical Nephrology 2016; 86: 51 –4.
- 7. Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN. Natural history and outcome in systemic AA amyloidosis. The New England journal of medicine 2007; 356: 2361-71.
- 8. Castano A, Narotsky DL, Hamid N et al. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J 2017; 38: 2879–87.
Ayrıntılar
Birincil Dil
Türkçe
Konular
Sağlık Kurumları Yönetimi
Bölüm
Olgu Sunumu
Yayımlanma Tarihi
30 Aralık 2020
Gönderilme Tarihi
14 Mayıs 2020
Kabul Tarihi
6 Temmuz 2020
Yayımlandığı Sayı
Yıl 2020 Cilt: 11 Sayı: 5